The Claim
In children with Graves' disease who achieve remission after antithyroid drug treatment, relapse can occur beyond the first year post-treatment, with some cases documented as late as two years after discontinuation.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Some children with Graves' disease who stop antithyroid drugs and appear to be in remission will experience a return of the disease more than one year later, and in some cases, this happens up to two years after stopping treatment.
See the scientific wording
In children with Graves' disease, relapse after remission can occur beyond the first year after stopping antithyroid drugs, with some cases occurring as late as 2 years post-treatment, highlighting the need for extended monitoring.
After treatment stops, immune cells continue to produce antibodies that trick the thyroid into making too much hormone, and these antibodies stay in the blood long enough to cause the disease to return even after a year or more.
What the research says
1 studyStudy: The role of the FT3/FT4 ratio in predicting remission and relapse in pediatric Graves’ disease
Even after kids with Graves' disease stop their medicine and seem fine, their body might still be hiding signs that the disease could come back later—this study found a blood test that can spot those hidden signs, so doctors should keep checking them for longer than just one year.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.